Europe Wearable Injectors Market to Grow at a CAGR of 11.3 % to reach US$ 3586.82 Million from 2020 to 2027

1. Introduction

1.1 Business Market Insights Research Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Hypothesis formulation:
3.2.2 Macro-economic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country level data:

4. Europe Wearable Injectors Market Landscape

4.1 Market Overview

4.2 Porter's Five Forces Analysis

4.2.1 Bargaining Power of Suppliers
4.2.2 Bargaining Power of Buyers
4.2.3 Threat of New Entrants
4.2.4 Competitive Rivalry
4.2.5 Threat of Substitutes

4.3 Ecosystem Analysis

4.3.1 Raw Material Suppliers
4.3.2 Manufacturers
4.3.3 Distributors/Suppliers
4.3.4 End Users

5. Europe Wearable Injectors Market – Key Market Dynamics

5.1 Growth Drivers

5.1.1 Surge in Demand for Wearable Injectors

5.2 Market Opportunities

5.2.1 New Product Launches and Approval

5.3 Future Trends

5.3.1 Integration With Telemedicine

5.4 Impact of Drivers and Restraints

6. Europe Wearable Injectors Market Regional Analysis

6.1 Europe Wearable Injectors Market Overview

6.2 Europe Wearable Injectors Market Revenue 2017-2027 (US$ Million)

6.3 Europe Wearable Injectors Market Forecast Analysis

7. Europe Wearable Injectors Market Analysis – by Type

7.1 On-Body Injectors

7.1.1 Overview
7.1.2 On-Body Injectors: Europe Wearable Injectors Market – Revenue and Forecast to 2031 (US$ Million)

7.2 Off-Body Injectors

7.2.1 Overview
7.2.2 Off-Body Injectors: Europe Wearable Injectors Market – Revenue and Forecast to 2031 (US$ Million)

8. Europe Wearable Injectors Market Analysis – by Application

8.1 Diabetes

8.1.1 Overview
8.1.2 Diabetes: Europe Wearable Injectors Market – Revenue and Forecast to 2027 (US$ Million)

8.2 Oncology

8.2.1 Overview
8.2.2 Oncology: Europe Wearable Injectors Market – Revenue and Forecast to 2027 (US$ Million)

8.3 Cardiovascular Disease

8.3.1 Overview
8.3.2 Cardiovascular Disease: Europe Wearable Injectors Market – Revenue and Forecast to 2027 (US$ Million)

8.4 Autoimmune Disease

8.4.1 Overview
8.4.2 Autoimmune Disease: Europe Wearable Injectors Market – Revenue and Forecast to 2027 (US$ Million)

8.5 Other Applications

8.5.1 Overview
8.5.2 Other Applications: Europe Wearable Injectors Market – Revenue and Forecast to 2027 (US$ Million)

9. Europe Wearable Injectors Market Analysis – by End User

9.1 Hospitals and Clinics

9.1.1 Overview
9.1.2 Other Applications: Europe Wearable Injectors Market – Revenue and Forecast to 2027 (US$ Million)

9.2 Homecare Setting

9.2.1 Overview
9.2.2 Other Applications: Europe Wearable Injectors Market – Revenue and Forecast to 2027 (US$ Million)

9.3 Other End User

9.3.1 Overview
9.3.2 Other Applications: Europe Wearable Injectors Market – Revenue and Forecast to 2027 (US$ Million)

10. Europe Wearable Injectors Market – Europe Analysis

10.1 Europe

10.1.1 Europe Wearable Injectors Market Breakdown, by Key Country, 2020 and 2027 (%)
10.1.1.1 Europe Wearable Injectors Market – Revenue and Forecast Analysis – by Country
10.1.1.1 UK: Europe Wearable Injectors Market – Revenue and Forecast to 2027 (US$ Million)

10.1.1.1.1 UK: Europe Wearable Injectors Market Breakdown, by Type
10.1.1.1.2 UK: Europe Wearable Injectors Market Breakdown, by Application
10.1.1.1.3 UK: Europe Wearable Injectors Market Breakdown, by End User

10.1.1.2 Germany: Europe Wearable Injectors Market – Revenue and Forecast to 2027 (US$ Million)

10.1.1.2.1 Germany: Europe Wearable Injectors Market Breakdown, by Type
10.1.1.2.2 Germany: Europe Wearable Injectors Market Breakdown, by Application
10.1.1.2.3 Germany: Europe Wearable Injectors Market Breakdown, by End User

10.1.1.3 France: Europe Wearable Injectors Market – Revenue and Forecast to 2027 (US$ Million)

10.1.1.3.1 France: Europe Wearable Injectors Market Breakdown, by Type
10.1.1.3.2 France: Europe Wearable Injectors Market Breakdown, by Application
10.1.1.3.3 France: Europe Wearable Injectors Market Breakdown, by End User

10.1.1.4 Russia: Europe Wearable Injectors Market – Revenue and Forecast to 2027 (US$ Million)

10.1.1.4.1 Russia: Europe Wearable Injectors Market Breakdown, by Type
10.1.1.4.2 Russia: Europe Wearable Injectors Market Breakdown, by Application
10.1.1.4.3 Russia: Europe Wearable Injectors Market Breakdown, by End User

10.1.1.5 Italy: Europe Wearable Injectors Market – Revenue and Forecast to 2027 (US$ Million)

10.1.1.5.1 Italy: Europe Wearable Injectors Market Breakdown, by Type
10.1.1.5.2 Italy: Europe Wearable Injectors Market Breakdown, by Application
10.1.1.5.3 Italy: Europe Wearable Injectors Market Breakdown, by End User

10.1.1.6 Rest of Europe: Europe Wearable Injectors Market – Revenue and Forecast to 2027 (US$ Million)

10.1.1.6.1 Rest of Europe: Europe Wearable Injectors Market Breakdown, by Type
10.1.1.6.2 Rest of Europe: Europe Wearable Injectors Market Breakdown, by Application
10.1.1.6.3 Rest of Europe: Europe Wearable Injectors Market Breakdown, by End User

11. Competitive Landscape

11.1 Heat Map Analysis

11.2 Company Positioning and Concentration

12. Europe Wearable Injectors Market Industry Landscape

12.1 Overview

12.2 Mergers and Acquisitions

12.3 Agreements, Collaborations, and Joint Ventures

12.4 New Product Launches

12.5 Expansions and Other Strategic Developments

13. Company Profiles

13.1 BD

13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments

13.2 CeQur SA

13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments

13.3 Debiotech S.A

13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments

13.4 E3D Elcam Drug Delivery Devices

13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments

13.5 Insulet Corporation

13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments

13.6 Gerresheimer AG

13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments

13.7 Tandem Diabetes Care Inc

13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments

13.8 Zealand Pharma A/S

13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments

13.9 West Pharmaceutical Services, Inc

13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments

13.10 Ypsomed AG

13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments

13.11 Medtronic

13.11.1 Key Facts
13.11.2 Business Description
13.11.3 Products and Services
13.11.4 Financial Overview
13.11.5 SWOT Analysis
13.11.6 Key Developments

13.12 Amgen, Inc

13.12.1 Key Facts
13.12.2 Business Description
13.12.3 Products and Services
13.12.4 Financial Overview
13.12.5 SWOT Analysis
13.12.6 Key Developments

14. Appendix

14.1 About Business Market Insights